Source-linked briefing Health

CEPI Backs Studies Testing Zaire Ebola Vaccines Against Bundibugyo Virus

CEPI Backs Studies Testing Zaire Ebola Vaccines Against Bundibugyo Virus

CEPI is funding four studies to assess whether vaccines developed for Zaire Ebola, including Ervebo, offer protection against the Bundibugyo virus. Findings could guide future outbreak responses and inform vaccine strategies across Ebola species.

Original headline

CEPI funds studies on Ebola vaccine protection against Bundibugyo virus